These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1583246

  • 1. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
    Findlay SR, Barden JM, Easley CB, Glass M.
    J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ, Glass M, Minkwitz MC.
    Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
    [Abstract] [Full Text] [Related]

  • 3. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
    Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT.
    Lancet; 1991 Mar 23; 337(8743):690-4. PubMed ID: 1672176
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
    O'Shaughnessy KM, Taylor IK, O'Connor B, O'Connell F, Thomson H, Dollery CT.
    Am Rev Respir Dis; 1993 Jun 23; 147(6 Pt 1):1431-5. PubMed ID: 8389105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.
    Hui KP, Barnes NC.
    Lancet; 1991 May 04; 337(8749):1062-3. PubMed ID: 1673495
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
    Smith LJ, Hanby LA, Lavins BJ, Simonson SG.
    Ann Allergy Asthma Immunol; 1998 Jul 04; 81(1):43-9. PubMed ID: 9690572
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
    Dahlén B, Kumlin M, Ihre E, Zetterström O, Dahlén SE.
    Thorax; 1997 Apr 04; 52(4):342-7. PubMed ID: 9196517
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z, Timmers MC, van der Veen H, Friedman BS, De Smet M, Depré M, Hilliard D, Bel EH, Sterk PJ.
    J Allergy Clin Immunol; 1995 Jan 04; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
    Swystun V, Green FHY, Dennis JH, Rampakakis E, Lalli G, Fadayomi M, Chiu A, Shrestha G, El Shahat SG, Nelson DE, El Mays TY, Pieron CA, Leigh R.
    Trials; 2018 Jun 18; 19(1):321. PubMed ID: 29914544
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL, Watson RM, Wyile G, O'Byrne PM.
    Thorax; 1997 Apr 18; 52(4):348-54. PubMed ID: 9196518
    [Abstract] [Full Text] [Related]

  • 18. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children.
    Pearlman DS, Ostrom NK, Bronsky EA, Bonuccelli CM, Hanby LA.
    J Pediatr; 1999 Mar 18; 134(3):273-9. PubMed ID: 10064661
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction.
    Richter K, Jörres RA, Magnussen H.
    Eur Respir J; 2000 Apr 18; 15(4):693-9. PubMed ID: 10780761
    [Abstract] [Full Text] [Related]

  • 20. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
    Makker HK, Lau LC, Thomson HW, Binks SM, Holgate ST.
    Am Rev Respir Dis; 1993 Jun 18; 147(6 Pt 1):1413-8. PubMed ID: 8389103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.